Sequenom Hits 52-Week High | GenomeWeb
NEW YORK (GenomeWeb News) – After matching a 52-week high of $23 on Monday before pulling back to close at $22.33 on the Nasdaq, up 6.4 percent for the day, shares of Sequenom hit a new 52-week high on Tuesday morning of $24.50.
 
The San Diego-based firm’s stock bucked the trend on a dismal Monday for the stock market, which saw the Dow Jones Industrial Average lose 241.81, or 2.1 percent, while the Nasdaq dropped 2 percent. The $23 per share price matched the firm’s 52-week high reached on July 16.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.